SyAllgen (Syntrion GmbH)
Welcome to the PulseAid listing for the SyAllgen drug offered from Syntrion GmbH. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Syntrion GmbH |
NON-PROPRIETARY NAME: | Penicillium Glabrum |
SUBSTANCE NAME: | PENICILLIUM GLABRUM |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | NASAL |
DOSAGE FORM: | SPRAY |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2011-02-25 |
END MARKETING DATE: | 2018-01-31 |
SyAllgen HUMAN OTC DRUG Details:
Item Description | SyAllgen from Syntrion GmbH |
LABELER NAME: | Syntrion GmbH |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 6([hp_X]/20mL) |
START MARKETING DATE: | 2011-02-25 |
END MARKETING DATE: | 2018-01-31 |
PRODUCT ID: | 10424-146_43df8239-ea51-4b1c-bbd5-a664d290cfb2 |
PRODUCT NDC: | 10424-146 |
APPLICATION NUMBER: | |
Other PENICILLIUM GLABRUM Pharmaceutical Manufacturers / Labelers: